NRP:JSENEPI Rockcastle N.V Analysis
Data as of 2026-05-24 - not real-time
ZAC 14,242.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
NEPI Rockcastle (NRP.JO) is trading at 14,242 ZAc, just above its 20‑day SMA of 14,156 and marginally below the 200‑day SMA of 14,248, indicating a neutral but slightly supportive price level. The RSI of 55 and a bullish MACD histogram (+2.75) suggest modest upward momentum, while increasing volume reinforces the technical optimism. Valuation metrics are compelling: a trailing PE of 10.6 versus an industry average of 32.7, a price‑to‑book of 1.04, and a DCF‑derived upside of roughly 5%, all pointing to an undervalued position. The stock offers a high dividend yield of 7.71% with a payout ratio near 80%, backed by solid operating cash flow of 453M ZAc, supporting the view that the dividend is sustainable. Analyst consensus is a “buy” with a median target of 14,988 ZAc, implying further upside. However, the company carries a net debt of over 2.8B ZAc and operates primarily in Central and Eastern Europe, exposing it to moderate geographic and regulatory risks. Overall, the blend of attractive valuation, strong cash generation, and a robust dividend makes NRP a compelling candidate for investors seeking value with income, while remaining mindful of leverage and regional exposure.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and rising volume signal near‑term price strength
- Attractive dividend yield with strong cash flow coverage
- Undervalued relative to peers (PE 10.6 vs industry 32.7)
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Upside potential to analyst median target (~5% above current price)
- Consistent revenue growth (~9% YoY) and high operating margins
- Sustainable dividend payout supported by free cash flow
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Exposure to CEE markets introduces geopolitical and regulatory uncertainty
- Leverage level (debt‑to‑equity ~62%) requires monitoring
- Stable income profile and low beta suggest defensive long‑run characteristics
Key Metrics & Analysis
Financial Health
Revenue Growth9.30%
Profit Margin53.60%
P/E Ratio10.6
ROE10.06%
ROA4.06%
Debt/Equity62.04
P/B Ratio1.0
Op. Cash FlowZAC453.5M
Free Cash FlowZAC232.9M
Industry P/E32.7
Technical Analysis
TrendNeutral
RSI55.3
SupportZAC 13,856.00
ResistanceZAC 14,504.00
MA 20ZAC 14,156.15
MA 50ZAC 13,960.16
MA 200ZAC 14,248.24
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61
Valuation
Fair ValueZAC 240.75
Target PriceZAC 14,909.91
Upside/Downside4.69%
GradeUndervalued
TypeBlend
Dividend Yield7.71%
Risk Assessment
Beta0.18
Volatility12.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.